Ozari vs Sesame for Weight Loss: Which GLP-1 Telehealth Platform is Right for You?

Sarah spent three weeks researching online weight loss programs before she realized something crucial: not all telehealth platforms offering semaglutide and tirzepatide are built the same way. She'd seen Sesame's advertisements promising access to weight loss medications, and she'd come across Ozari's offerings for compounded GLP-1s at $99 per month. The prices seemed similar at first glance, but as she dug deeper, she discovered the platforms operate on fundamentally different models—and those differences would affect everything from her monthly costs to the type of medication she'd receive.

If you're comparing Ozari and Sesame for weight loss treatment, you're not alone. Both platforms have gained attention in the rapidly expanding GLP-1 telehealth space, but they serve different needs and offer distinct approaches to accessing these medications. Understanding these differences can save you hundreds of dollars and help you find the care model that actually fits your life.

The Fundamental Difference: Marketplace vs. Direct Care Provider

Here's the most important thing to understand right away: Ozari and Sesame operate on completely different business models, and this affects nearly every aspect of your experience.

Sesame functions as a healthcare marketplace. Think of it like an Expedia for medical services—they connect you with independent healthcare providers who set their own prices and protocols. When you use Sesame for weight loss, you're paying for a consultation with a provider on their platform, and then that provider writes a prescription that you'll fill separately, either through a pharmacy that Sesame connects you with or through your own pharmacy. The provider you see, the medication source, and even the follow-up care structure can vary depending on which clinician you book with on the platform.

Ozari takes a different approach entirely. We operate as a direct telehealth provider with our own clinical team. When you become an Ozari patient, you're working with our employed or contracted medical professionals who follow consistent protocols based on current evidence and clinical guidelines. Your medication is included in your monthly subscription fee—it's not a separate transaction. We source compounded semaglutide and tirzepatide from FDA-registered 503B facilities, and we ship directly to your door as part of your monthly service.

This structural difference cascades into everything else: pricing transparency, continuity of care, medication access, and how you communicate with your medical team. In our clinical experience, patients often don't realize they're comparing two fundamentally different service models until they've already started the process with one platform or the other.

The marketplace model isn't inherently better or worse—it offers flexibility and may give you access to brand-name medications if that's your preference and budget allows. But it does mean you'll need to navigate multiple relationships: one with Sesame, one with your specific provider, and potentially another with your pharmacy. For some patients, especially those comfortable coordinating their own care, this works fine. Others find it adds complexity they weren't expecting.

Pricing Structures: Monthly Subscriptions vs. À La Carte Services

Let's talk real numbers, because this is where things get interesting and where many patients find unexpected costs.

Ozari's pricing is straightforward: compounded semaglutide or tirzepatide starts at $99 per month, which includes your medication, shipping, and ongoing clinical support. Your initial consultation is included. There aren't separate fees for the doctor visit, the prescription, and the medication—it's one monthly subscription that covers your treatment. As you increase doses, your monthly cost may adjust, but you'll know your price before you commit to the next month.

Sesame's pricing is more variable because you're paying for services unbundled. You'll see consultation fees listed on their platform—often ranging from $29 to $99 for a weight loss consultation with a provider. That sounds reasonable until you realize that's just for the visit. The medication is a separate cost entirely. If your provider prescribes brand-name Wegovy or Zepbound, you're looking at $1,000 to $1,400 per month unless you have insurance coverage that includes these medications (which many plans still don't). If they prescribe compounded versions, the cost drops considerably—often to $200 to $400 per month depending on the pharmacy and dose—but that's still on top of your consultation fee.

Here's what we see frequently in our patients who've switched from marketplace platforms: they were attracted to a low consultation fee but didn't fully account for the ongoing medication costs. One patient told us she paid $49 for her Sesame consultation, felt great about the affordable access, then discovered her monthly medication cost would be $350. Over six months, that's $2,149 compared to $594 with Ozari's pricing model.

Sesame does offer a membership program called Sesame Plus at $99 per year, which provides discounts on services and medications. This can reduce costs if you're using multiple Sesame services, but for weight loss treatment specifically, you're still paying separately for consultations and medications on top of that annual fee.

The pricing structure you prefer depends partly on how you like to manage healthcare expenses. Some people prefer seeing exactly what they're paying for each service. Others want the simplicity of one predictable monthly charge. Neither approach is wrong, but it's worth calculating the total cost over three to six months—the typical timeframe for seeing significant results with GLP-1 medications—rather than just comparing initial consultation fees.

Medication Sources: Compounded vs. Brand-Name Options

The type of medication you'll receive differs significantly between these platforms, and this matters more than many patients initially realize.

Ozari exclusively provides compounded semaglutide and tirzepatide from FDA-registered 503B outsourcing facilities. These are specialized compounding pharmacies that operate under stricter federal oversight than traditional compounding pharmacies. The medications contain the same active ingredients as Wegovy, Ozempic, Mounjaro, and Zepbound—semaglutide and tirzepatide—but they're prepared by compounding pharmacies rather than pharmaceutical manufacturers. This is what allows us to offer these medications at $99 per month instead of over $1,000.

Compounded GLP-1 medications became widely available when the FDA placed semaglutide and tirzepatide on shortage lists, which legally permits compounding pharmacies to prepare these medications. The active ingredient is the same, but the inactive ingredients (the solution it's suspended in, preservatives, etc.) may differ from brand-name versions. In our clinical experience, the vast majority of patients respond just as well to compounded versions, though we acknowledge that pharmaceutical companies argue their formulations go through more rigorous testing.

Sesame's marketplace model means medication options vary by provider. Some providers on the platform prescribe brand-name medications exclusively. Others work with compounding pharmacies and will prescribe compounded versions. Still others offer patients a choice based on budget and insurance coverage. This flexibility can be an advantage if you specifically want brand-name Wegovy or Zepbound and have insurance that covers it, or if you've tried compounded medication elsewhere and want to switch to pharmaceutical versions.

The catch is that you won't always know which type of medication the provider prescribes until you're in the consultation. Sesame's platform shows provider prices and specialties, but medication preferences aren't always listed upfront. You might book with a provider offering a $39 consultation only to discover they exclusively prescribe brand-name medications your insurance doesn't cover.

There's also the question of supply consistency. Because Ozari works directly with 503B facilities with established relationships, we've been able to maintain consistent supply for our patients even as demand for GLP-1 medications has surged. Marketplace platforms depend on multiple pharmacy relationships, which can mean more variability in availability. Several patients have told us they experienced frustrating delays with previous providers when their pharmacy ran out of medication and they had to wait for restocking or find an alternative source.

Clinical Support and Ongoing Care

Weight loss with GLP-1 medications isn't a one-and-done prescription. These treatments require dose adjustments, side effect management, and ongoing monitoring—which is where the care model really matters.

At Ozari, your ongoing clinical support is built into your monthly subscription. You have access to our care team through our patient portal for questions between visits. We proactively check in about side effects, especially when you're titrating up to new doses. Your medication arrives at your door each month without you needing to coordinate with a separate pharmacy. If you need a dose adjustment or have concerns, you're communicating with the same clinical team that knows your history.

With Sesame's marketplace approach, ongoing care depends entirely on which provider you selected. Some providers on the platform offer comprehensive follow-up care with regular check-ins and responsive messaging. Others operate more like a traditional prescription service—you have your consultation, get your prescription, and then you're responsible for scheduling follow-up appointments when needed. Each additional consultation typically means another fee, though follow-ups are often less expensive than initial visits.

This isn't necessarily a drawback if you're someone who prefers to manage your own care and only wants to check in with a provider when you feel it's necessary. But GLP-1 medications work best with consistent medical oversight. The STEP 1 trial, which demonstrated that semaglutide leads to an average 14.9% body weight reduction over 68 weeks, involved regular medical monitoring and dose adjustments. Real-world results tend to be best when patients have that same level of structured support.

We've also noticed that medication continuity becomes simpler with a direct-care model. When your clinical team and your pharmacy are coordinated under one system, there's no back-and-forth about refills or dose changes. One of our patients who switched from a marketplace platform told us her previous experience involved calling the provider's office for a dose increase, waiting for them to send a new prescription to the pharmacy, then calling the pharmacy to confirm they received it and had the medication in stock. With Ozari, she messages through the portal, and her next shipment arrives with the adjusted dose.

What Women Should Know

Women make up the majority of patients seeking GLP-1 therapy for weight loss, and there are some specific considerations worth thinking about when choosing between these platforms.

If you're planning pregnancy, currently pregnant, or breastfeeding, you shouldn't use semaglutide or tirzepatide—this is consistent across all providers and platforms. But if you're of reproductive age and not planning pregnancy, you need to know that these medications can affect hormonal contraception effectiveness, particularly if you're experiencing nausea and vomiting. This requires ongoing conversation with your provider, and having consistent access to the same clinical team makes those conversations easier.

Women also tend to experience GI side effects from GLP-1 medications slightly more frequently than men, particularly nausea in the first few weeks of treatment or after dose increases. Having responsive clinical support during these adjustment periods can make the difference between pushing through temporary side effects and abandoning treatment entirely. Ask yourself which model—marketplace flexibility or direct integrated care—would give you more confidence that you'll have support when you need it.

Another consideration: many women are juggling weight loss treatment alongside other health management, whether that's thyroid medication, antidepressants, or treatments for PCOS. If you're already working with multiple providers, adding a marketplace platform where you might see different clinicians creates another coordination challenge. A direct-care provider like Ozari means fewer relationships to manage.

What Men Should Know

Men have historically been underrepresented in weight loss programs, but that's changing rapidly with GLP-1 medications. If you're a guy comparing these platforms, here's what matters.

First, men tend to lose weight faster on these medications, with the SURMOUNT-1 trial showing that while both sexes benefited significantly from tirzepatide, men often saw slightly more rapid initial weight loss. This might mean you'll titrate up to higher doses more quickly, which affects pricing on platforms that charge per dose tier. With Ozari's model, you're not worrying about jumping price brackets as you increase doses within your treatment plan.

Men are also more likely to be managing weight loss alongside cardiovascular concerns. The SELECT trial demonstrated that semaglutide reduced major cardiovascular events by 20% in patients with existing heart disease—a finding that made headlines in 2023. If you've got a history of heart disease or you're treating obesity partly for cardiac risk reduction, you want a provider who's thinking comprehensively about your health. Whether you'll get that through a marketplace platform depends on which individual provider you connect with.

Practically speaking, many men prefer healthcare that doesn't require much active management. You want something that works without constant coordination. That typically favors integrated models where medication automatically arrives and follow-up is built into the system rather than something you need to schedule repeatedly.

From the Ozari Care Team

We recommend thinking about your decision in terms of what you'll need six months from now, not just today. The initial consultation fee might seem like the most important factor right now, but you're beginning a treatment that works best with consistency over many months. Choose the platform that you'll actually stick with when you hit the challenging middle months, when the initial excitement has worn off and you need reliable support and affordable medication to keep going. In our experience, the patients who succeed long-term are those who've found a care model that removes obstacles rather than adding them.

Key Takeaways

• Ozari operates as a direct telehealth provider with integrated care, while Sesame functions as a marketplace connecting you with independent providers—this fundamental difference affects everything from pricing to continuity of care
• Ozari's all-inclusive pricing starts at $99/month for compounded GLP-1 medication including shipping and support, while Sesame charges separately for consultations and medications, with total costs varying widely based on provider and medication type
• Ozari exclusively offers compounded semaglutide and tirzepatide, while Sesame providers may prescribe brand-name or compounded medications depending on the individual clinician you see
• Ongoing clinical support is built into Ozari's monthly subscription, whereas Sesame's marketplace model means follow-up structure and costs depend on your specific provider
• Calculate total treatment costs over 3-6 months rather than just comparing initial consultation fees—the real expense difference becomes clear when you account for ongoing medication and follow-up visits

Frequently Asked Questions

Can I use insurance with Ozari or Sesame for GLP-1 weight loss medications?

Currently, Ozari doesn't bill insurance directly because we provide compounded medications, which aren't typically covered by insurance plans. However, our $99/month pricing is designed to be more affordable than most insurance copays for brand-name GLP-1s anyway. With Sesame, insurance acceptance varies by provider—some providers on the platform accept insurance for consultations, and if they prescribe brand-name medications, you may be able to use insurance at the pharmacy depending on your plan's coverage. Keep in mind that many insurance plans still don't cover GLP-1 medications for weight loss, only for diabetes, so you'll want to verify your specific coverage before assuming insurance will help.

What happens if I have side effects or need to adjust my dose with each platform?

With Ozari, you can reach out to our care team through your patient portal anytime you're experiencing side effects or think you need a dose adjustment. We'll review your situation and make changes to your treatment plan, with your adjusted medication arriving in your next shipment. There's no additional charge for this clinical support—it's part of your monthly subscription. On Sesame, you'll need to contact the specific provider you initially consulted with, which may require scheduling another appointment depending on their practice policies. Some providers include limited messaging for quick questions, but significant concerns often mean another paid visit. Ask about follow-up policies before your initial Sesame consultation so you know what to expect.

How quickly can I start treatment with Ozari vs Sesame?

Both platforms can move pretty quickly once you complete the initial steps. With Ozari, you'll fill out a health intake form, have an asynchronous consultation with our medical team (we review your information and approve treatment without requiring a live video call for straightforward cases), and if approved, your medication typically ships within a few days. From start to first injection, most patients begin within a week. Sesame's timeline depends on provider availability—you might get a same-day or next-day video consultation slot, but then you're waiting for the provider to send your prescription and for the pharmacy to fill and ship it, which can add several days to a week. Neither platform is dramatically faster than the other, but Ozari's integrated approach means fewer steps where things might get delayed.

Are compounded GLP-1 medications from Ozari as safe as brand-name versions from traditional pharmacies?

Compounded semaglutide and tirzepatide from FDA-registered 503B facilities contain the same active ingredients as brand-name versions—the molecules are identical. The difference is in manufacturing setting and inactive ingredients. We source exclusively from 503B facilities, which face federal oversight and inspection requirements beyond what standard compounding pharmacies deal with. That said, they don't go through the same multi-year FDA approval process as pharmaceutical manufacturers. Clinical data from trials like STEP 1 and SURMOUNT-1 used pharmaceutical versions, so we're extrapolating their safety profiles to compounded versions. In our clinical experience with thousands of patients, we see comparable effectiveness and safety profiles, but it's fair to say pharmaceutical companies have more extensive long-term data. For most patients, the dramatic cost difference ($99/month vs $1,200+/month) makes compounded versions the only realistic option.

Can I switch from Sesame to Ozari or vice versa if I'm not happy with my choice?

Absolutely, and we see patients switch between platforms fairly regularly. If you start with Sesame and decide you want the integrated care model and pricing of Ozari, you can sign up with us anytime. We'll review your treatment history, verify what dose you're currently on, and continue your care from there. Just don't stop your current medication abruptly—maintain your current supply until your Ozari medication arrives to avoid a gap in treatment. Switching from Ozari to Sesame works similarly—there's no long-term contract or cancellation penalty. You'd schedule a consultation with a Sesame provider, explain your current treatment and dose, and they'd write a new prescription. The main thing to coordinate is timing your last shipment from one provider and your first shipment from the next so you don't run out of medication or end up with redundant supplies you've paid for.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.